Companies › MEDP
MEDPACE HLDGS INC (MEDP)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001668397 · EDGAR filings · Updated 2026-07-28
MEDPACE HLDGS INC (MEDP) has reported institutional ownership of 86.1%, with 725 institutional managers holding positions valued at $11.5B per the latest 13F reporting period.
Filings this week (6)
- 2026-07-28 — Notice of proposed sale filed (Form 144)
- 2026-07-28 — Notice of proposed sale filed (Form 144)
- 2026-07-27 — Notice of proposed sale filed (Form 144)
- 2026-07-23 — Notice of proposed sale filed (Form 144)
- 2026-07-23 — Quarterly report (10-Q) filed
- 2026-07-22 — Current report (8-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, MEDPACE HLDGS INC has 725 institutional holders and institutional ownership of 86.1%.
Insider activity
Insiders reported 70 transactions (0 buys, 37 sells) across 9 reporting insiders, with a net reported value of −$326.4M.
Related companies
MADRIGAL PHARMACEUTICALS INC (MDGL) · JAZZ PHARMACEUTICALS PLC (JAZZ) · ALIGN TECHNOLOGY INC (ALGN) · PENUMBRA INC (PEN) · EXELIXIS INC (EXEL) · ENSIGN GROUP INC (ENSG)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.